The NLRP3 inflammasome in viral infection (Review).

Qiaoli Zheng, Chunting Hua, Qichang Liang, Hao Cheng
Author Information
  1. Qiaoli Zheng: Department of Dermatology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, P.R. China.
  2. Chunting Hua: Department of Dermatology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, P.R. China.
  3. Qichang Liang: Department of Dermatology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, P.R. China.
  4. Hao Cheng: Department of Dermatology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, P.R. China.

Abstract

The interplay between pathogen and host determines the immune response during viral infection. The Nod‑like receptor (NLR) protein 3 inflammasome is a multiprotein complex that induces the activation of inflammatory caspases and the release of IL‑1β, which play an important role in the innate immune responses. In the present review, the mechanisms of the NLR family pyrin domain containing 3 inflammasome activation and its dysregulation in viral infection were addressed.

Keywords

References

  1. Nat Rev Immunol. 2023 Mar 27;: [PMID: 36973360]
  2. Front Cell Infect Microbiol. 2023 May 15;13:1149911 [PMID: 37256114]
  3. J Immunol. 2007 Mar 15;178(6):3837-45 [PMID: 17339483]
  4. Immunity. 2004 Mar;20(3):319-25 [PMID: 15030775]
  5. J Biol Chem. 2004 Dec 10;279(50):51729-38 [PMID: 15383541]
  6. Front Immunol. 2020 Mar 10;11:352 [PMID: 32210961]
  7. Nat Immunol. 2019 May;20(5):527-533 [PMID: 30962589]
  8. Nat Immunol. 2008 Aug;9(8):847-56 [PMID: 18604214]
  9. Infect Immun. 2022 Jul 21;90(7):e0066321 [PMID: 35678562]
  10. Nat Immunol. 2023 Jul;24(7):1064-1075 [PMID: 37277654]
  11. Nat Commun. 2018 Jan 9;9(1):106 [PMID: 29317641]
  12. Biochem Pharmacol. 2021 May;187:114385 [PMID: 33359010]
  13. Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9035-40 [PMID: 18577586]
  14. Cell. 2010 Mar 19;140(6):821-32 [PMID: 20303873]
  15. Cell Rep. 2015 Jul 7;12(1):42-48 [PMID: 26119741]
  16. J Immunol. 2015 Dec 15;195(12):5732-49 [PMID: 26538395]
  17. PLoS Pathog. 2023 May 8;19(5):e1011381 [PMID: 37155697]
  18. Virology. 2011 Apr 10;412(2):306-14 [PMID: 21315400]
  19. Int J Biochem Cell Biol. 2020 May;122:105738 [PMID: 32156572]
  20. Commun Biol. 2023 May 30;6(1):578 [PMID: 37253813]
  21. Eur J Immunol. 2015 Oct;45(10):2911-7 [PMID: 26174085]
  22. Front Microbiol. 2019 Jan 29;10:50 [PMID: 30761102]
  23. PLoS Pathog. 2009 Aug;5(8):e1000559 [PMID: 19696895]
  24. Nature. 2019 Jun;570(7761):338-343 [PMID: 31189953]
  25. J Biol Chem. 2012 Oct 19;287(43):36617-22 [PMID: 22948162]
  26. Nature. 2006 Apr 20;440(7087):1064-8 [PMID: 16625199]
  27. Cell Death Dis. 2019 Apr 25;10(5):346 [PMID: 31024004]
  28. Immunity. 2009 Apr 17;30(4):556-65 [PMID: 19362020]
  29. Cell Host Microbe. 2015 Apr 8;17(4):466-77 [PMID: 25816776]
  30. iScience. 2020 Jul 24;23(7):101270 [PMID: 32592999]
  31. J Immunol. 2009 Jul 15;183(2):792-6 [PMID: 19542372]
  32. J Clin Invest. 2020 Dec 1;130(12):6301-6316 [PMID: 33104527]
  33. Nature. 2006 Mar 9;440(7081):228-32 [PMID: 16407890]
  34. Cell Death Discov. 2023 May 10;9(1):155 [PMID: 37165005]
  35. Cell. 2023 May 25;186(11):2288-2312 [PMID: 37236155]
  36. Cell. 2006 Sep 22;126(6):1135-45 [PMID: 16990137]
  37. Nat Immunol. 2008 Aug;9(8):857-65 [PMID: 18604209]
  38. Nature. 2012 Aug 30;488(7413):670-4 [PMID: 22801494]
  39. J Neuroinflammation. 2021 Jan 5;18(1):1 [PMID: 33402173]
  40. J Immunol. 2012 Oct 15;189(8):3795-9 [PMID: 22984081]
  41. Nat Commun. 2015 Feb 06;6:6115 [PMID: 25655831]
  42. Annu Rev Immunol. 2022 Apr 26;40:249-269 [PMID: 35080918]
  43. Nat Immunol. 2010 Jan;11(1):63-9 [PMID: 19915568]
  44. Front Immunol. 2020 Nov 27;11:585146 [PMID: 33329561]
  45. Front Microbiol. 2021 Feb 09;12:570093 [PMID: 33633700]
  46. Mol Cell. 2013 Jan 24;49(2):331-8 [PMID: 23246432]
  47. Immune Netw. 2019 Dec 23;19(6):e40 [PMID: 31921470]
  48. EMBO Mol Med. 2019 Jun;11(6): [PMID: 31015277]
  49. Nat Immunol. 2010 Feb;11(2):136-40 [PMID: 20023662]
  50. EMBO J. 1995 Apr 18;14(8):1607-14 [PMID: 7737113]
  51. J Biol Chem. 2014 Nov 21;289(47):32926-36 [PMID: 25288801]
  52. Front Immunol. 2021 Sep 16;12:747370 [PMID: 34603335]
  53. Cell Death Differ. 2001 Jun;8(6):649-57 [PMID: 11536016]
  54. Immunology. 2021 Mar;162(3):249-251 [PMID: 33590488]
  55. J Virol. 2018 Mar 28;92(8): [PMID: 29386291]
  56. J Biol Chem. 2019 May 24;294(21):8325-8335 [PMID: 30940725]
  57. J Biol Chem. 2007 Feb 2;282(5):2871-9 [PMID: 17132626]
  58. Immunity. 2015 Aug 18;43(2):264-76 [PMID: 26275995]
  59. J Biol Chem. 2014 Aug 1;289(31):21716-26 [PMID: 24939850]
  60. Am J Physiol Cell Physiol. 2022 Apr 1;322(4):C645-C652 [PMID: 35171697]
  61. Virology. 2014 Jan 20;449:174-80 [PMID: 24418550]
  62. Biosci Trends. 2020 May 21;14(2):74-82 [PMID: 32295992]
  63. Cell. 2013 Apr 11;153(2):348-61 [PMID: 23582325]
  64. Immunity. 2012 Mar 23;36(3):401-14 [PMID: 22342844]
  65. Eur J Immunol. 2015 Oct;45(10):2918-26 [PMID: 26173988]
  66. Infect Immun. 2007 Mar;75(3):1484-92 [PMID: 17178784]
  67. J Hepatol. 2017 Apr;66(4):693-702 [PMID: 28027970]
  68. J Microbiol. 2021 Jun;59(6):616-625 [PMID: 33779957]
  69. J Virol. 2011 Dec;85(24):13019-26 [PMID: 21994456]
  70. Sci Immunol. 2021 Oct 22;6(64):eabj3859 [PMID: 34678046]
  71. Front Immunol. 2019 Nov 28;10:2791 [PMID: 31849970]
  72. J Virol. 2018 Sep 12;92(19): [PMID: 30021903]
  73. J Virol. 2018 Jan 30;92(4): [PMID: 29187536]
  74. Front Immunol. 2020 Feb 18;11:211 [PMID: 32133002]
  75. J Immunol. 2009 Jul 15;183(2):787-91 [PMID: 19570822]
  76. PLoS Pathog. 2012;8(8):e1002857 [PMID: 22916014]
  77. Front Cell Dev Biol. 2023 May 12;11:1173235 [PMID: 37250902]
  78. Nat Immunol. 2013 Dec;14(12):1247-55 [PMID: 24185614]
  79. Nat Rev Immunol. 2013 Jun;13(6):397-411 [PMID: 23702978]
  80. PLoS Pathog. 2015 Sep 14;11(9):e1005155 [PMID: 26367131]
  81. Immunology. 2021 Aug;163(4):377-388 [PMID: 34042182]
  82. Front Immunol. 2022 Aug 30;13:987453 [PMID: 36110852]
  83. Cell Death Discov. 2023 Apr 29;9(1):142 [PMID: 37120628]
  84. J Leukoc Biol. 2020 Nov;108(5):1655-1663 [PMID: 32386456]
  85. Nat Commun. 2014 Sep 30;5:4977 [PMID: 25266676]
  86. Nature. 2008 Mar 6;452(7183):103-7 [PMID: 18288107]
  87. Front Immunol. 2020 Jun 23;11:1518 [PMID: 32655582]
  88. Inflamm Res. 2020 Jul;69(7):683-696 [PMID: 32347316]
  89. RNA Biol. 2020 Mar;17(3):335-349 [PMID: 31840571]
  90. PLoS Pathog. 2019 Sep 3;15(9):e1007934 [PMID: 31479495]
  91. Nat Immunol. 2014 Apr;15(4):343-53 [PMID: 24531343]
  92. Int J Mol Sci. 2019 Jul 06;20(13): [PMID: 31284572]
  93. Cell Death Dis. 2019 Dec 2;10(12):906 [PMID: 31787755]
  94. Int J Mol Sci. 2020 Jun 13;21(12): [PMID: 32545788]
  95. PLoS Pathog. 2013;9(4):e1003256 [PMID: 23592984]
  96. Front Immunol. 2023 Jan 18;13:1109938 [PMID: 36741414]
  97. Science. 2008 May 2;320(5876):674-7 [PMID: 18403674]
  98. Mol Aspects Med. 2020 Dec;76:100924 [PMID: 33187725]
  99. Cell. 2000 Sep 29;103(1):99-111 [PMID: 11051551]
  100. J Virol. 2013 May;87(9):5005-18 [PMID: 23427152]
  101. Biochem J. 2013 Feb 1;449(3):613-21 [PMID: 23110696]
  102. Viruses. 2015 Jun 24;7(7):3380-91 [PMID: 26114475]
  103. Front Microbiol. 2022 Jun 02;13:926915 [PMID: 35722277]
  104. J Biol Chem. 2017 Jan 20;292(3):826-836 [PMID: 27913620]
  105. Nat Immunol. 2014 Dec;15(12):1126-33 [PMID: 25326752]
  106. Front Immunol. 2019 Feb 28;10:276 [PMID: 30873162]

MeSH Term

Humans
Inflammasomes
NLR Family, Pyrin Domain-Containing 3 Protein
Virus Diseases
Immunity, Innate
Caspases
Interleukin-1beta

Chemicals

Inflammasomes
NLR Family, Pyrin Domain-Containing 3 Protein
Caspases
Interleukin-1beta

Word Cloud

Created with Highcharts 10.0.0infectioninflammasomeimmuneviralresponseNLR3activationinnateNLRP3interplaypathogenhostdeterminesNod‑likereceptorproteinmultiproteincomplexinducesinflammatorycaspasesreleaseIL‑1βplayimportantroleresponsespresentreviewmechanismsfamilypyrindomaincontainingdysregulationaddressedReviewregulationvirus

Similar Articles

Cited By